Year-to-year changes in lung function in individuals with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 9, Issue 4, 2010, Pages 250-256

  Liou, Theodore G ^a   Elkin, Eric P ^b   Pasta, David J ^b   Jacobs, Joan R ^c   Konstan, Michael W ^d   Morgan, Wayne J ^e   Wagener, Jeffrey S ^f  

^a UNIVERSITY OF UTAH   (United States)

^b ICON CLINICAL RESEARCH   (United States)

^c GENENTECH INC   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f UNIVERSITY OF COLORADO   (United States)

Author keywords

Annual trends; Cystic fibrosis; Pulmonary function

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LONGITUDINAL STUDY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PATIENT MONITORING; POPULATION RESEARCH; TREND STUDY; AGE; CLINICAL TRIAL; DISEASE COURSE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CYSTIC FIBROSIS; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 77953913894     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2010.04.002     Document Type: Article

References (33)

1. Kerem E., Reisman J., Corey M., Canny G.J., Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med Apr 30 1992, 326(18):1187-1191.
2. Liou T.G., Adler F.R., Fitzsimmons S.C., Cahill B.C., Hibbs J.R., Marshall B.C. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol Feb 15 2001, 153(4). 345-52.
3. Schluchter M.D., Konstan M.W., Davis P.B. Jointly modelling the relationship between survival and pulmonary function in cystic fibrosis patients. Stat Med May 15 2002, 21(9):1271-1287.
4. Shwachman H., Kulczycki L.L. Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. AMA J Dis Child Jul 1958, 96(1):6-15.
5. Taussig L.M., Kattwinkel J., Friedewald W.T., Di Sant'Agnese P.A. A new prognostic score and clinical evaluation system for cystic fibrosis. J Pediatr Mar 1973, 82(3):380-390.
6. Kulich M., Rosenfeld M., Campbell J., Kronmal R., Gibson R.L., Goss C.H., et al. Disease-specific reference equations for lung function in patients with cystic fibrosis. Am J Respir Crit Care Med Oct 1 2005, 172(7):885-891.
7. Burrows B., Earle R.H. Chronic obstructive lung disease. N Engl J Med May 22 1969, 280(21):1183-1184.
8. Mannino D.M., Reichert M.M., Davis K.J. Lung function decline and outcomes in an adult population. Am J Respir Crit Care Med May 1 2006, 173(9):985-990.
9. Corey M., Edwards L., Levison H., Knowles M. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. J Pediatr Dec 1997, 131(6):809-814.
10. Rosenbluth D.B., Wilson K., Ferkol T., Schuster D.P. Lung function decline in cystic fibrosis patients and timing for lung transplantation referral. Chest Aug 2004, 126(2):412-419.
11. 1 changes related to antibiotic therapy in children with cystic fibrosis. Ir Med J Aug 2007, 100(7):529-532.
12. Liou T.G., Adler F.R., Cahill B.C. Testing lung function decline to time lung transplantation. Chest Jul 2005, 128(1):472-473. author reply 473-474.
13. Mayer-Hamblett N., Aitken M.L., Accurso F.J., Kronmal R.A., Konstan M.W., Burns J.L., et al. Association between pulmonary function and sputum biomarkers in cystic fibrosis. Am J Respir Crit Care Med Apr 15 2007, 175(8):822-828.
14. 1 among adult asthmatics. Eur Respir J Jan 2003, 21(1):95-100.
15. 1 decline in patients with COPD using other respiratory medications. Evid Based Med Apr 2009, 14(2):42-43.
16. Morgan W.J., Butler S.M., Johnson C.A., Colin A.A., FitzSimmons S.C., Geller D.E., et al. Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada. Pediatr Pulmonol Oct 1999, 28(4):231-241.
17. 1 decline in cystic fibrosis. Am J Respir Crit Care Med Oct 15 2008, 178(8):814-821.
18. Yucesoy B., Kurzius-Spencer M., Johnson V.J., Fluharty K., Kashon M.L., Guerra S., et al. Association of cytokine gene polymorphisms with rate of decline in lung function. J Occup Environ Med Jun 2008, 50(6):642-648.
19. Cazzato S., Poletti V., Bernardi F., Loroni L., Bertelli L., Colonna S., et al. Airway inflammation and lung function decline in childhood post-infectious bronchiolitis obliterans. Pediatr Pulmonol Apr 2008, 43(4):381-390.
20. Martínez-García M.A., Soler-Cataluña J., Perpiñá-Tordera M., Román-Sánchez P., Soriano J. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest Nov 2007, 132(5):1565-1572.
21. Cystic Fibrosis Foundation Cystic Fibrosis Foundation Patient Registry 2006 Annual Data Report 2007, Cystic Fibrosis Foundation, Bethesda, Maryland.
22. Foundation Cystic Fibrosis Internet Available from. http://www.cff.org/LivingWithCF/CareCenterNetwork/QualityImprovement/.
23. Glindmeyer H.W., Diem J.E., Jones R.N., Weill H. Noncomparability of longitudinally and cross-sectionally determined annual change in spirometry. Am Rev Respir Dis May 1982, 125(5):544-548.
24. Cox D.R., Fitzpatrick R., Fletcher A.E., Gore S.M., Spiegelhalter D.J., Jones D.R. Quality-of-life assessment: can we keep it simple?. J R Stat Soc Ser A (Stat Soc) 1992, 155(3):353-393.
25. Quanjer P.H. A 10year follow up of 180 adults with bronchial asthma: factors important for the decline in lung function. Thorax Jun 1992, 47(6):484.
26. Chaudemanche H., Monnet E., Westeel V., Pernet D., Dubiez A., Perrin C., et al. Respiratory status in dairy farmers in France; cross sectional and longitudinal analyses. Occup Environ Med Nov 2003, 60(11):858-863.
27. Peat J.K., Woolcock A.J., Cullen K. Decline of lung function and development of chronic airflow limitation: a longitudinal study of non-smokers and smokers in Busselton, Western Australia. Thorax Jan 1990, 45(1):32-37.
28. Wang X., Dockery D.W., Wypij D., Fay M.E., Ferris B.G. Pulmonary function between 6 and 18years of age. Pediatr Pulmonol Feb 1993, 15(2):75-88.
29. Hankinson J.L., Odencrantz John R., Fedan Kathleen B. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med Jan 1 1999, 159(1):179-187.
30. Stanojevic S., Wade A., Stocks J., Hankinson J., Coates A.L., Pan H., et al. Reference ranges for spirometry across all ages: a new approach. Am J Respir Crit Care Med Feb 1 2008, 177(3):253-260.
31. Johnson C., Butler S.M., Konstan M.W., Morgan W., Wohl M.E.B. Factors influencing outcomes in cystic fibrosis: a center-based analysis. Chest Jan 2003, 123(1):20-27.
32. Chapman K.R., Stockley R.A., Dawkins C., Wilkes M.M., Navickis R.J. Augmentation therapy for alpha1 antitrypsin deficiency: a meta-analysis. COPD Jun 2009, 6(3):177-184.
33. Konstan M.W., Morgan W.J., Butler S.M., Pasta D.J., Craib M.L., Silva S.J., et al. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr Aug 2007, 151(2):134-139. 139.e1.